Kerri Nottage

4.0k total citations · 1 hit paper
36 papers, 2.2k citations indexed

About

Kerri Nottage is a scholar working on Hematology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Kerri Nottage has authored 36 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 21 papers in Genetics and 14 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Kerri Nottage's work include Hemoglobinopathies and Related Disorders (17 papers), Iron Metabolism and Disorders (12 papers) and Childhood Cancer Survivors' Quality of Life (7 papers). Kerri Nottage is often cited by papers focused on Hemoglobinopathies and Related Disorders (17 papers), Iron Metabolism and Disorders (12 papers) and Childhood Cancer Survivors' Quality of Life (7 papers). Kerri Nottage collaborates with scholars based in United States, France and United Kingdom. Kerri Nottage's co-authors include Melissa M. Hudson, Deo Kumar Srivastava, Leslie L. Robison, Kirsten K. Ness, James G. Gurney, Wassim Chemaitilly, Gregory T. Armstrong, Daniel A. Mulrooney, Kevin R. Krull and Daniel M. Green and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Kerri Nottage

36 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Ascertainment of Health Outcomes Among Adults Treated for Childhood Cancer

2013 877 citations Melissa M. Hudson, Kirsten K. Ness et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kerri Nottage United States	18	1.2k	752	662	553	463	36	2.2k
Arja Harila‐Saari Sweden	25	1.1k 1.0×	378 0.5×	1.1k 1.7×	331 0.6×	435 0.9×	132	2.2k
Liton Francisco United States	34	1.5k 1.3×	1.7k 2.3×	1.2k 1.8×	1.1k 1.9×	301 0.7×	109	3.9k
Guđmundur Jónmundsson Iceland	24	871 0.7×	752 1.0×	1.2k 1.8×	409 0.7×	187 0.4×	47	2.0k
Stanislaw Garwicz Sweden	31	1.2k 1.0×	740 1.0×	1.4k 2.2×	539 1.0×	443 1.0×	94	3.0k
Amanda Termuhlen United States	25	702 0.6×	209 0.3×	624 0.9×	438 0.8×	305 0.7×	74	1.8k
Anne Mäkipernaa Finland	24	608 0.5×	794 1.1×	556 0.8×	279 0.5×	385 0.8×	70	2.0k
Bernward Zeller Norway	27	491 0.4×	1.4k 1.8×	790 1.2×	339 0.6×	191 0.4×	86	2.2k
Guido Pastore Italy	28	1.3k 1.1×	157 0.2×	999 1.5×	611 1.1×	239 0.5×	101	2.9k
Karsten Nysom Denmark	25	797 0.7×	292 0.4×	740 1.1×	425 0.8×	210 0.5×	109	2.0k
Claire Berger France	21	534 0.5×	369 0.5×	441 0.7×	163 0.3×	167 0.4×	84	1.3k

Countries citing papers authored by Kerri Nottage

Since Specialization

Citations

This map shows the geographic impact of Kerri Nottage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerri Nottage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerri Nottage more than expected).

Fields of papers citing papers by Kerri Nottage

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerri Nottage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerri Nottage. The network helps show where Kerri Nottage may publish in the future.

Co-authorship network of co-authors of Kerri Nottage

This figure shows the co-authorship network connecting the top 25 collaborators of Kerri Nottage. A scholar is included among the top collaborators of Kerri Nottage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerri Nottage. Kerri Nottage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pabst, Thomas, Norbert Vey, Lionel Adès, et al.. (2023). Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy. Haematologica. 108(7). 1793–1802. 25 indexed citations

Burke, G.A. Amos, Luciana Vinti, Edita Kabíčková, et al.. (2022). Ibrutinib plus RICE or RVICI for relapsed/refractory mature B-cell non-Hodgkin lymphoma in children and young adults: SPARKLE trial. Blood Advances. 7(4). 602–610. 6 indexed citations

Beishuizen, Auke, Deepa Bhojwani, Birgit Burkhardt, et al.. (2019). IBRUTINIB + CHEMOIMMUNOTHERAPY (CIT) FOR RELAPSED/REFRACTORY MATURE B‐CELL NON‐HODGKIN LYMPHOMA (B‐NHL) IN CHILDREN (SPARKLE TRIAL): INITIAL SAFETY, PK, AND EFFICACY. Hematological Oncology. 37(S2). 57–59. 2 indexed citations

Nottage, Kerri, et al.. (2017). State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease. Pediatric Drugs. 20(1). 29–42. 10 indexed citations

Estepp, Jeremie H., Matthew P. Smeltzer, Guolian Kang, et al.. (2017). A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy. American Journal of Hematology. 92(12). 1333–1339. 63 indexed citations

Neunert, Cindy, Jenny M. Despotovic, Kristina M. Haley, et al.. (2016). Thrombopoietin Receptor Agonist Use in Children: Data From the Pediatric ITP Consortium of North America ICON2 Study. Pediatric Blood & Cancer. 63(8). 1407–1413. 58 indexed citations

Schaefer, Beverly A., Jonathan M. Flanagan, Ofelia Álvarez, et al.. (2016). Genetic Modifiers of White Blood Cell Count, Albuminuria and Glomerular Filtration Rate in Children with Sickle Cell Anemia. PLoS ONE. 11(10). e0164364–e0164364. 27 indexed citations

Nottage, Kerri, Russell E. Ware, Banu Aygün, et al.. (2016). Hydroxycarbamide treatment and brain MRI/MRA findings in children with sickle cell anaemia. British Journal of Haematology. 175(2). 331–338. 30 indexed citations

Hankins, Jane S., et al.. (2015). Severe Autoimmune Hemolytic Anemia in an Infant Caused by Warm-reactive IGM and IGA Autoantibodies. Journal of Pediatric Hematology/Oncology. 37(6). 468–471. 6 indexed citations

10.

Nolan, Val, et al.. (2015). Prevalence of Vitamin D Deficiency in Sickle Cell Disease: A Systematic Review. PLoS ONE. 10(3). e0119908–e0119908. 46 indexed citations

11.

Whipple, Nicholas, et al.. (2015). Paroxysmal cold hemoglobinuria due to an IgA Donath–Landsteiner antibody. Pediatric Blood & Cancer. 62(11). 2044–2046. 6 indexed citations

12.

Smeltzer, Matthew P., Val Nolan, Xinhua Yu, et al.. (2015). Distance from an Urban Sickle Cell Center and its Effects on Routine Healthcare Management and Rates of Hospitalization. Hemoglobin. 40(1). 10–15. 7 indexed citations

13.

Sheehan, Vivien, Jacy R. Crosby, Aniko Sabo, et al.. (2014). Whole Exome Sequencing Identifies Novel Genes for Fetal Hemoglobin Response to Hydroxyurea in Children with Sickle Cell Anemia. PLoS ONE. 9(10). e110740–e110740. 28 indexed citations

14.

Hankins, Jane S., Banu Aygün, Kerri Nottage, et al.. (2014). From Infancy to Adolescence. Medicine. 93(28). e215–e215. 58 indexed citations

15.

Nottage, Kerri, Russell E. Ware, Matthew P. Smeltzer, et al.. (2014). Predictors of splenic function preservation in children with sickle cell anemia treated with hydroxyurea. European Journal Of Haematology. 93(5). 377–383. 24 indexed citations

16.

Hudson, Melissa M., Kirsten K. Ness, James G. Gurney, et al.. (2013). Clinical Ascertainment of Health Outcomes Among Adults Treated for Childhood Cancer. JAMA. 309(22). 2371–2371. 877 indexed citations breakdown →

17.

Nottage, Kerri, Jane S. Hankins, Matthew P. Smeltzer, et al.. (2013). Hydroxyurea Use and Hospitalization Trends in a Comprehensive Pediatric Sickle Cell Program. PLoS ONE. 8(8). e72077–e72077. 27 indexed citations

18.

Nottage, Kerri, et al.. (2012). Trends in transfusion burden among long-term survivors of childhood hematological malignancies. Leukemia & lymphoma. 54(8). 1719–1723. 17 indexed citations

19.

Gawade, Prasad L., Kirsten K. Ness, Shelly Sharma, et al.. (2012). Association of bone mineral density with incidental renal stone in long-term survivors of childhood acute lymphoblastic leukemia. Journal of Cancer Survivorship. 6(4). 388–397. 2 indexed citations

20.

Nottage, Kerri, Jennifer Q. Lanctot, Zhenghong Li, et al.. (2011). Long-term risk for subsequent leukemia after treatment for childhood cancer: a report from the Childhood Cancer Survivor Study. Blood. 117(23). 6315–6318. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact